Mycelex-7

Mycelex-7 is part of the drug classes:

• Antiinfectives and antiseptics for local oral treatment

• Imidazole and triazole derivatives

• Imidazole derivatives

No drug interactions have been reported by the manufacturer. However, you should tell your doctor about all the medicines you take including prescription and non-prescription medicines, vitamins, and herbal supplements. Not all drug interactions are known or reported and new drug interactions are continually being reported.

Tell your doctor if you are pregnant or plan to become pregnant.

The FDA categorizes medications based on safety for use during pregnancy. Five categories - A, B, C, D, and X, are used to classify the possible risks to an unborn baby when a medication is taken during pregnancy.

Topical clotrimazole cream and solution fall into category B. In animal studies, pregnant animals were given clotrimazole, and some babies had problems. But in human studies, pregnant women were given this medication and their babies did not have any problems related to this medication.

Clotrimazole lozenges fall into category C. There are no well-controlled studies that have been done in pregnant women. Clotrimazole should be used during pregnancy only if the possible benefit outweighs the possible risk to the unborn baby.

Use this medication exactly as prescribed by your doctor. Follow the directions on your prescription label carefully.

The dose your doctor recommends may be based on the following:

• the condition being treated
• other medical conditions you have
• how you respond to this medication

Topical cream:

The recommended dose of clotrimazole cream and solution for the treatment of skin infections is 1% cream or solution massaged into the affected skin twice daily for two to eight weeks.

Oral lozenges:

The recommended dose of clotrimazole lozenges for the treatment of yeast infections of the mouth is the use of one lozenge five times daily for fourteen days.  The recommended dose of clotrimazole lozenges for the prevention of yeast infections of the mouth is the use of one lozenge three times daily for the duration of a patient’s immunocompromised state, such as during chemotherapy, radiotherapy, or steroid therapy.